Reflection Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-1,978
Closed -$107K – 158
2025
Q4
$107K Buy
+1,978
New +$95.2K 0.08% 152

Other funds holding BMY

Reflection Asset Management's BMY Position: Q1 2026 in Review

Reflection Asset Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 1,978 shares — an estimated $107K sold.

Reflection Asset Management first reported a position in BMY in Q4 2025 and held it in 1 quarter. The position peaked at $107K in Q4 2025. 2,543 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Reflection Asset Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Reflection Asset Management sold 1,978 Bristol-Myers Squibb shares in Q1 2026, an estimated $107K.
  • Reflection Asset Management first reported a position in Bristol-Myers Squibb in Q4 2025 and held it in 1 quarter.
  • Reflection Asset Management's Bristol-Myers Squibb position peaked at $107K in Q4 2025.
  • 2,543 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Reflection Asset Management's 13F filing for Q1 2026, filed 26 Aug 2026.